BCR and metabolic syndrome: Our data demonstrate that the impaired diastolic function of type 2 diabetic and MetS patients was not dependent on increased myocardial fibrosis, cardiomyocyte hypertrophy, alteration of the myocardial microvascular structure, or increased myocardial expression of CML or RAGE.